Eli Lilly and Novo Nordisk have announced they are working on new oral drugs that can be used for type-2 diabetes and weight ...
The manufacturers of Ozempic and Mounjaro are creating oral weight loss medications that could change treatment methods. These daily pills, pending FDA approval, reportedly show significant results in ...
And Big Pharma’s not done cashing in on the weight-loss boom. Drugmakers are readying a new wave of next-level GLP-1 ...
Eli Lilly announced trial results for its weight-loss medication, orforglipron, in August. Orforglipron is a once-daily oral ...
Ozempic 2.0 really means the next generation weight loss booster, creating buzz for its advanced results, improved ...